Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure
NCT ID: NCT06913283
Last Updated: 2025-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
136 participants
INTERVENTIONAL
2025-05-02
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars
NCT03838094
Efficacy of PRF and MTA as Compared to Calcium Hydroxide for Pulpotomy in Human Irreversibly Inflamed Permanent Teeth
NCT05266859
Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA
NCT03890835
Bioactive Materials in Pulp Therapy of Primary Teeth
NCT04795830
Comparative Evaluation of Calcium Silicate-doped Treated Dentin Matrix and Mineral Trioxide Aggregate as Miniature Pulpotomy Biomaterials in Deep Carious Lesions
NCT07302438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A Mineral trioxide aggregate pulpotomy
Pulp Therapy with Mineral trioxide aggregate (MTA)
MTA allowed to set for twenty four hours
Group B Biodentine pulpotomy
Pulp Therapy with Biodentine
Biodentine is triturated before use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulp Therapy with Mineral trioxide aggregate (MTA)
MTA allowed to set for twenty four hours
Pulp Therapy with Biodentine
Biodentine is triturated before use
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Altamash Institute of Dental Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ambreen Mengal
Dentist AMengal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Altamash Institute of Dental Medicine
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Dr. Zahid Iqbal
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Altamash IDM Ambreen
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.